Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
4 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Alumis Inc.’s names, not what it holds today.
Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 2 in 2024 and 1 in 2023
Applications published
9
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Alumis Inc. its own name
named as the applicant on its applications, in US. 1 more under the same name are not counted (printed in JP)
9 publishedAlumis Inc. its own name
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in JP)
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jul 8, 2025 | 12,351,572 | Substituted 1,2,4-triazoles as TYK2 inhibitors | Organic fine chemistry | Alumis Inc. |
| Aug 13, 2024 | 12,060,343 | Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors | Organic fine chemistry | Alumis Inc. |
| Jun 11, 2024 | 12,006,306 | Substituted pyridazines as TYK2 inhibitors | Organic fine chemistry | Alumis Inc. |
| Aug 22, 2023 | 11,731,956 | Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors | Organic fine chemistry | Alumis Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 11, 2025 | 2025/0376459 | CRYSTALLINE FORMS OF A TYK2 INHIBITOR AND USES THEREOF | Pharmaceuticals | Alumis Inc. |
| Sep 4, 2025 | 2025/0276977 | TYK2 INHIBITORS AND USES THEREOF | Organic fine chemistry | Alumis Inc. |
| Jul 3, 2025 | 2025/0213571 | TYK2 INHIBITORS AND USES THEREOF | Organic fine chemistry | Alumis Inc. |
| Jun 26, 2025 | 2025/0205211 | TYK2 INHIBITORS AND USES THEREOF | Pharmaceuticals | Alumis Inc. |
| Jun 12, 2025 | 2025/0188093 | TYK2 INHIBITORS AND USES THEREOF | Organic fine chemistry | Alumis Inc. |
| Dec 7, 2023 | 2023/0391751 | SUBSTITUTED 1,2,4-TRIAZOLES AS INTERMEDIATES IN THE SYNTHESIS OF TYK2 INHIBITORS | Organic fine chemistry | Alumis Inc. · patent 12,351,572 granted from it |
| Nov 9, 2023 | 2023/0357273 | TYK2 INHIBITORS AND USES THEREOF | Organic fine chemistry | Alumis Inc. |
| Jan 26, 2023 | 2023/0021554 | TYK2 INHIBITORS AND USES THEREOF | Organic fine chemistry | Alumis Inc. · patent 11,731,956 granted from it |
| Jul 28, 2022 | 2022/0235035 | TYK2 INHIBITORS AND USES THEREOF | Organic fine chemistry | Alumis Inc. · patent 12,060,343 granted from it |
What it applied for, 2024 to 2025: Organic fine chemistry 3 · Pharmaceuticals 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.